Monsanto enters into CRISPR/Cas licensing deal

28-09-2016

Monsanto enters into CRISPR/Cas licensing deal

360b / shutterstock.com

Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.


Monsanto, CRISPR-Cas, genome editing, Broad Institute, Harvard, patent

LSIPR